In this week’s episode of Weekly Extractions, Adam talks about some of the highlights coming out of the psychedelic sector this week. Psychedelic Invest’s own, Adam Tubero, shares his thoughts on the Compass Pathways lawsuit, MindMed’s former Chief Medical Officer now an activist shareholder, Cybin’s at-the-money market offering, and the implications of Mydecin’s four directors…